Patents by Inventor Luc Morris

Luc Morris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR PREDICTING IMMUNE CHECKPOINT BLOCKADE EFFICACY ACROSS MULTIPLE CANCER TYPES
    Publication number: 20240282410
    Abstract: The present disclosure relates generally to methods, devices, and systems for accurately predicting the efficacy of immune checkpoint blockade therapy across multiple cancer types.
    Type: Application
    Filed: June 17, 2022
    Publication date: August 22, 2024
    Inventors: Luc Morris, Timothy Chan, Diego Chowell, Cristina Valero, Nils Weinhold, Seong-Keun Yoo
  • TUMOR MUTATIONAL LOAD
    Publication number: 20220340663
    Abstract: The present invention encompasses the discovery that the likelihood of a favorable response to cancer immunotherapy for a wide range of different cancers can be predicted through definition of a tumor mutational load threshold for the tumor (and/or the relevant immunotherapy).
    Type: Application
    Filed: November 29, 2021
    Publication date: October 27, 2022
    Inventors: Timothy A. Chan, Diego Chowell Puente, Robert M. Samstein, Luc Morris
  • Tumor mutational load
    Patent number: 11230599
    Abstract: The present invention encompasses the discovery that the likelihood of a favorable response to cancer immunotherapy for a wide range of different cancers can be predicted through definition of a tumor mutational load threshold for the tumor (and/or the relevant immunotherapy).
    Type: Grant
    Filed: September 25, 2018
    Date of Patent: January 25, 2022
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Timothy A. Chan, Diego Chowell Puente, Robert M. Samstein, Luc Morris
  • TUMOR MUTATIONAL LOAD
    Publication number: 20190092864
    Abstract: The present invention encompasses the discovery that the likelihood of a favorable response to cancer immunotherapy for a wide range of different cancers can be predicted through definition of a tumor mutational load threshold for the tumor (and/or the relevant immunotherapy).
    Type: Application
    Filed: September 25, 2018
    Publication date: March 28, 2019
    Inventors: Timothy A. Chan, Diego Puente Chowell, Robert M. Samstein, Luc Morris